Tag: clinical trial

April 2, 2019

Hemispherx Announces First Participant Received Initial Dosing in Breast Cancer Clinical Trial

Hemispherx (NYSE American:HEB) has announced the active initiation of a clinical trial sponsored by Roswell Park Comprehensive Cancer Center, evaluating...
March 8, 2019

AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena

AMAG Pharmaceuticals (NASDAQ:AMAG) has announced topline results from its PROLONG trial evaluating Makena in patients with a history of a...
March 4, 2019

Tetra Bio-Pharma Finishes Second Stage of Cannabis Trial

Tetra Bio-Pharma announced the completion of a phase two clinical trial of cannabis oil capsules treating uncontrolled chronic pain in cancer and non-cancer...
February 8, 2019

Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa

Catalyst Biosciences (NASDAQ:CBIO) has announced it has presented updated interim data from its Phase 2/3 trial of subcutaneous prophylactic Factor VIIa...
December 11, 2018

Acerus Announces Results of Phase 1 Clinical Trial with a Proprietary Intranasal Formulation of a Tetrahydrocannabinol-Rich Cannabis Oil

Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) is today providing results of a Phase 1 clinical trial (the “trial”)...
December 3, 2018

4 Gene Therapy Companies to Watch

What gene therapy companies should be on investors' radar? Here are four promising companies to consider looking at in 2018.
November 13, 2018

CRISPR Trials to Watch in 2018

CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.